Guest
Tanishq Abraham
Co-founder & CEO, Sophont
Real Alpha has cut 5 moments of Tanishq Abraham (Co-founder & CEO, Sophont) talking, from an interview on MTS published Oct 21, 2026.
What Tanishq Abraham said
Tumor slides can reveal biology that guides personalized care
“this one gene, which was actually then targeted by the medical team for treatment for this patient”
Tanishq Abraham4:13 Cancer AI could support research, drug development, and care
“if you can predict the treatment response using the features from Hall and S1, then you can tell a patient”
Tanishq Abraham11:27 AI drug discovery needs evidence from human biology
“we need to actually be training AI models on clinical data and on human biology.”
Tanishq Abraham13:47 Cancer AI tools could reach clinical trials within a year
“some of these tools could potentially reach these clinical trials, at the very least, definitely like retrospective trials, potentially even prospective trials.”
Tanishq Abraham21:50 Patient tests may matter before new drugs reach the clinic
“that can be done in a lot quicker timeline, in my opinion, compared to like developing drugs from scratch.”
Tanishq Abraham16:39
The episode
MTSCancer AI Models Will Reach Clinical Trials Within a Year | Tanishq Abraham
Tanishq Abraham · Co-founder & CEO, Sophont
0:36of 25:04 · Oct 21
